Metabolon
Metabolon, Mayo Clinic Partner to Develop Metabolomic Biomarker Tests
The company will analyze patient samples from Mayo Clinic to look for disease biomarkers and design diagnostic tests.
In Brief This Week: Interpace, Now Diagnostics, Metabolon, and More
Interpace Diagnostics Group announced this week that it has entered into an agreement with Acupath Laboratories through which Acupath will sell Interpace's ThyGenX and ThyraMIR tests.
Metabolon Buys German Metabolomics Firm
The deal increases Metabolon's access to the European market and builds on its goal of bringing the value of metabolomics globally, according its CEO John Ryals.
The three-year-old firm anticipates entering the clinical space later this year with a launch of its metabolomics-based test in Finland.
Metabolon, Zhejiang Dian Ink China Commercialization Deal
Dian will install Metabolon's Discovery HD4 metabolomics platform in its Hangzhou laboratory, and will commercialize Metabolon's products throughout China.